Suppr超能文献

术前症状分类是否会影响接受根治性肾输尿管切除术治疗的局限性上尿路上皮癌患者的预后?

Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?

机构信息

New York-Presbyterian Hospital-Weill Cornell Medical Center, New York, NY 10021, USA.

出版信息

Urol Oncol. 2011 Nov-Dec;29(6):716-23. doi: 10.1016/j.urolonc.2009.11.007. Epub 2010 Jan 6.

Abstract

OBJECTIVES

To evaluate if preoperative symptom classification could refine prediction of outcomes for patients with clinically localized upper-tract urothelial carcinoma (UTUC) managed by radical nephroureterectomy (RNU).

METHODS

Data on 654 patients with localized UTUC who underwent RNU were reviewed. Preoperative symptoms were classified as incidental (S1), local (S2), and systemic (S3). Clinical and pathologic data were compared between the cohorts. Kaplan-Meier analyses and Cox proportional hazard modeling were used to determine recurrence-free and cancer-specific survival amongst the symptom cohorts.

RESULTS

Symptom classification was S1 in 213 (33%) patients, S2 in 402 (61%), and S3 in 39 (6%). S3 symptoms were associated with advanced pathology, including higher stage, grade, and lymph node (LN) positivity. Five and 10-year recurrence-free and cancer-specific survival estimates were similar for patients with S1 and S2 symptoms (P = 0.75 and 0.58, respectively), but was worse for patients with S3 symptoms (P < 0.001 for both). On multivariate analysis adjusting for final pathologic stage, grade, and LN status, S3 symptoms were not an independent predictor of recurrence (HR 1.44, P = 0.19) or death due to disease (HR 1.66, P = 0.07). Addition of symptom classification, however, increased the accuracy of a model consisting of stage, grade, and LNs for prediction of recurrence-free and cancer-specific survival by 1.4% and 1.3%, respectively (P < 0.001 for both).

CONCLUSIONS

Local symptoms do not confer worse prognosis compared with patients with incidentally detected UTUC. However, systemic symptoms are associated with worse outcomes despite apparently effective RNU. Patients with systemic symptoms may harbor micrometastatic disease and could potentially benefit from a more rigorous metastatic evaluation or perioperative chemotherapy regimens.

摘要

目的

评估术前症状分类是否能改善接受根治性肾输尿管切除术(RNU)治疗的局限性上尿路上皮癌(UTUC)患者的预后预测。

方法

回顾了 654 例接受 RNU 治疗的局限性 UTUC 患者的数据。将术前症状分为偶发(S1)、局部(S2)和全身(S3)。比较了队列之间的临床和病理数据。Kaplan-Meier 分析和 Cox 比例风险模型用于确定症状队列之间的无复发生存和癌症特异性生存。

结果

S1 症状患者 213 例(33%),S2 症状患者 402 例(61%),S3 症状患者 39 例(6%)。S3 症状与高级别病理相关,包括更高的分期、分级和淋巴结(LN)阳性。S1 和 S2 症状患者的 5 年和 10 年无复发生存和癌症特异性生存估计值相似(P=0.75 和 0.58),但 S3 症状患者的生存较差(P<0.001)。在调整最终病理分期、分级和 LN 状态的多变量分析中,S3 症状不是复发的独立预测因素(HR 1.44,P=0.19)或疾病相关死亡的预测因素(HR 1.66,P=0.07)。然而,症状分类的加入分别使基于分期、分级和 LN 的模型预测无复发生存和癌症特异性生存的准确性提高了 1.4%和 1.3%(P<0.001)。

结论

与偶然发现的 UTUC 患者相比,局部症状不会导致预后更差。然而,全身症状与更差的结果相关,尽管 RNU 似乎有效。全身症状患者可能存在微转移疾病,可能受益于更严格的转移评估或围手术期化疗方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验